Saga Chemie Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.12 M
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -21.11%
- Profit Growth -35.03%
- Ebitda -43.91%
- Net Worth 19.79%
- Total Assets 2.13%
About Saga Chemie
Saga Chemie Private Limited (SCPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 July 2010 and has a history of 14 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Pritam Mulaokar and Pradeep Mulaokar serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100MH2010PTC205294
- Company No.
205294
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jul 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Saga Chemie Private Limited offer?
Saga Chemie Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Root and Vegetable Extracts, Plant Extracts, Fruit Extracts, Herbal Extracts.
Who are the key members and board of directors at Saga Chemie?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pritam Mulaokar  | Director | 06-Jul-2010 | Current |
| Pradeep Mulaokar | Director | 06-Jul-2010 | Current |
Financial Performance of Saga Chemie.
Saga Chemie Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 21.11% decrease. The company also saw a substantial fall in profitability, with a 35.03% decrease in profit. The company's net worth Soared by an impressive increase of 19.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saga Chemie?
In 2021, Saga Chemie had a promoter holding of 83.33% and a public holding of 16.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Beta Molecules LlpPradeep Mulaokar is a mutual person
- Zephyr Speciality Chemicals Private Limited
Pradeep Mulaokar is a mutual person
- Novel Molecules Private Limited
Pradeep Mulaokar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Saga Chemie?
Unlock and access historical data on people associated with Saga Chemie, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saga Chemie, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saga Chemie's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.